A modified human interferon-or 2 was produced in Escherichia coli cells infected with phage M13 mp7 containing an interferon-~ gene. After purification by immunochromatography with the monoclonal antibody NK2, the N-terminal amino acid sequence was determined. The N-terminal methionine was absent but an additional sequence of 18 amino acids at the N-terminus was retained. The modified interferon-or2 was indistinguishable from authentic interferon-~2 in its ability to activate natural killer cells, to slow the growth of Daudi cells, and to confer virus resistance on heterologous cells.
We have recently reported the use of phage MI3 mp7 as a vector for high level expression of an interferon-ct z gene (Slocombe et al., 1982) . The predicted amino acid sequence of the recombinant interferon contained an additional 19 amino acids at the N-terminus, although this could not be confirmed by direct determination of the N-terminal amino acid by the dansylation method. The recombinant interferon was recognized by the monoclonal antibody to interferon-~, NK2, and had a similar specific activity as assessed by the immunoradiometric assay (Secher & Burke, 1980; Secher, 1981) . It also showed cross-species antiviral activity similar to a mixture of interferon-~ species. It seemed, therefore, that either the additional amino acids at the Nterminus had no effect on antiviral activity or that the recombinant product had been processed by proteolytic cleavage to remove the additional amino acids. We now report that only the Nterminal methionine residue is removed, and that the additional 18 amino acids at the Nterminus have no effect on several biological activities of interferon-~2.
The bacterial interferon-c~2 was prepared as described by Slocombe et al. (1982) except that double-strength YT broth was used, since on average threefold more interferon was produced. Variations in a number of other parameters [carbon source, density of the bacterial culture, multiplicity of infection and concentration of isopropyl-fl-D-thiogalactopyranoside (IPTG)] had little effect on the interferon yield. Indeed, cultures incubated in the absence of IPTG produced interferon from about 2-5 h after infection, the final yield being 10 to 25~ of that obtained from induced cultures, suggesting that the replication of the phage may titrate out the lac repressor produced by the bacterial chromosome.
When the crude product from the bacterial cultures was purified on NK2-Sepharose as described by Slocombe et al. (1982) , and analysed by polyacrylamide gel electrophoresis, the major component had a mol. wt. of 20 500. However, there were also small amounts of some proteins of higher molecular weight in the gel. These were shown to be bacterial products by use of the M 13 mp7-ct2 clone designated W26 (Slocombe et aL, 1982) in which the orientation of the interferon gene is reversed, so that no interferon is produced. Purification of the lysate from a W26-infected culture by immunochromatography on NK2-Sepharose showed that these minor bands were still present and represented non-specifically bound proteins, accounting for a small proportion (<20~) of purified interferon-~2 preparations. Table 1 
Quantification of phenylthiohydantoin (PTH)-amino acids identified at each cycle*
Residue number The N-terminal analysis of a sample of the purified product was determined on a modified Beckman 890B Sequencer and the phenylthiohydantoin (PTH)-amino acids identified as described by Brock & Walker (1980) on a Zorbax OD5 column (DuPont) ( Table 1 and Fig. 1 ). Several PTH-amino acids were identified at each cycle, indicating heterogeneity of the starting material but by quantification of the results it was possible to identify a major residue at each position ( Table 1 ). The major residues agreed well with the inferred sequence, the only apparent discrepancies being at residues that are difficult to identify and quantify. The results showed that the N-terminal methionine had been removed but suggested that otherwise the whole amino acid sequence predicted from the nucleotide sequence was present. The minor residues at positions 1 and 2 could be due to a small amount of initiation at the second methionine at position 3, to incomplete loss of the N-terminal methionine, or to other E. coli proteins present in the interferon preparation. At step 1 of the degradation about 5 nmol of threonine was released, and since the number of antiviral units was known to be 5 x 106, this gave a figure for the specific activity of 0.5 x 108 International Units (IU)/mg protein, in reasonable agreement with the previous figure of 2 × 108 units/mg protein for this material (Slocombe et al., 1982) , which was similar to that reported for unmodified IFN-az of 3 x l0 s IU/mg protein (Rubinstein, 1982) .
This modified interferon-a2, with its 18 additional amino acids, was then compared with authentic interferon-a2, a gift of Dr R. Lawn (Genentech Inc., San Francisco, Ca., U.S.A.), in its ability to activate natural killer (NK) cells, to slow cell growth and to confer virus resistance on non-human cells. The ability to activate NK cells was measured by lysis of SlCr-labelled K562 cells as described by Moore & Potter (1980) , using unfractionated lymphocytes at a 20 : 1 effector to target ratio. The two preparations of interferon showed similar activity: treatment with 1000 IU of modified interferon-a2 (with the additional amino acids) caused a rise in cytotoxicity from 35 % (control) to 42%, while the same number of units of authentic interferonc~z caused a rise to 43%. The ability to slow cell growth was measured by adding different amounts of the interferons to Daudi cells growing in suspension in RPMI 1640 medium plus 10% foetal calf serum. After 48 h growth in the presence of interferon the modified interferon gave a 50% depression of the growth rate at 44 units/ml, while the same effect was given by 58 IU/ml of authentic interferon-a: (see Gewart et al., 1981) . Finally, the antiviral effect of the two interferons was compared on a number of different cell lines, by means of an RNA reduction assay (Atherton & Burke, 1975) . Table 2 shows that the two interferons had very similar effects on several different cell lines, the results for IFN-~2 being very similar to those reported by Weck et al. (1981b) for IFN-a. It is clear that the relative activity of the two interferons was very similar on the different cell lines. We conclude that the three-dimensional structure of the novel interferon is similar to that of authentic interferon-~2 and, since folding is presumably initiated at the N-terminal end, that such initiation of folding is unaffected by the additional amino acids. Recently, it has been shown that loss of 10 ( Levy et al., 1981) or 11 (Franke et al., 1982) amino acids from the C-terminal end of an interferon molecule either had no measurable effect on the specific activity (when 10 are missing), or only reduced it to onethird (when 11 are missing). However, changes further into the coding regions do produce substantial changes in antiviral activity in non-human cells (Streuli et al., 1981; Weck et al., Short communication 1981a; Franke et al., 1982) . Thus, the regions of the interferon molecule involved in its biological activities are beginning to be identified, although no one region of the molecule has yet been identified as the sole determinant of antiviral activity on mammalian cells (see Franke et al., 1982) .
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